J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval

Summary: Good news for people with psoriasis! The FDA just approved a new once-a-day pill called Icotyde. It is made by Johnson & Johnson and Protagonist Therapeutics. For a long time, patients had to use shots to get strong relief from itchy, flaky skin. Now, they can just take this pill with water every morning when they wake up.

In tests, 70% of people saw their skin become clear or almost clear. It even beat another popular pill in a head-to-head test. Doctors are calling it a "game-changer" for the 8 million Americans with plaque psoriasis. Experts think this new medicine could make up to $7.5 billion because it is so easy to use and works so well.

For more details, see rssapp-fiercepharma-com at fiercepharma.com/pharma/jj-protagonists-game-changer-once-daily-psoriasis-pill-icotyde-nabs-fda-approval (opens in new tab)